SCHEMBL5336763

SCHEMBL5336763

C=CCC(c1ccccc1)N(C(=O)O)C(C)(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.50
CYP2C19 P33261 3/20 0.49
KDM4E B2RXH2 1/20 0.38
ATM Q13315 1/20 0.38
RIPK1 Q13546 1/20 0.36
LMNA P02545 2/20 0.35
CHRNB2 P17787 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA4 P43681 1/20 0.35
MAPT P10636 1/20 0.35
ALDH1A1 P00352 3/20 0.35
TSHR P16473 1/20 0.35
MEN1 O00255 1/20 0.34
HTT P42858 1/20 0.34
KMT2A Q03164 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
OPRM1 P35372 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4352633 0.86 KDM4E (0.39) SMN1; SMN2CYP2C19KDM4EATMRIPK1
SCHEMBL1274248 0.86 KDM4E (0.39) SMN1; SMN2CYP2C19KDM4EATMRIPK1
SCHEMBL17644864 0.85 SMN1; SMN2 (0.39) SMN1; SMN2CYP2C19RIPK1MAPTALDH1A1
SCHEMBL17644866 0.85 SMN1; SMN2 (0.39) SMN1; SMN2CYP2C19RIPK1MAPTALDH1A1
SCHEMBL18918308 0.81 HTR2A (0.43) CYP2C19KDM4EL3MBTL1
SCHEMBL18918310 0.81 HTR2A (0.43) CYP2C19KDM4EL3MBTL1
SCHEMBL18918312 0.81 HTR2A (0.43) CYP2C19KDM4EL3MBTL1
SCHEMBL531655 0.81 RIPK1 (0.42) CYP2C19KDM4EATMRIPK1LMNA
SCHEMBL19305428 0.81 RIPK1 (0.42) CYP2C19KDM4EATMRIPK1LMNA
SCHEMBL19305426 0.81 RIPK1 (0.42) CYP2C19KDM4EATMRIPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1814537-A2 MACROCYCLIC TERTIARY AMINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Merck & Co., Inc. (US) 2007-08-08 EP disclosed
WO-2006055434-A2 MACROCYCLIC TERTIARY AMINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK & CO., INC. (US) 2006-05-26 WO disclosed